Země: Německo
Jazyk: angličtina
Zdroj: HMA (Heads of Medicines Agencies)
meloxicam 1.25 mg
aniMedica GmbH
QM01AC06
Suspension for injection
meloxicam
Dogs
2009-10-22
Revised: September 2013 AN. 01030/2012 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Animeloxan 1.5 mg/ml oral suspension for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of suspension contains: Active substance: Meloxicam 1.5 mg (equivalent to 0.05 mg per drop) Excipient: Sodium benzoate 1.5 mg (equivalent to 0.05 mg per drop) For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oral suspension The product is a pale yellow viscous suspension. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dog 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders. 4.3 CONTRAINDICATIONS Do not use in pregnant or lactating animals. Do not use in animals suffering from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic disorders. Do not use in case of hypersensitivity to the active substance or to any of the excipients. Do not use in dogs less than 6 weeks of age. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None Revised: September 2013 AN. 01030/2012 Page 2 of 6 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS If adverse reactions occur, treatment should be discontinued and the advice of a veterinarian should be sought. Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of increased renal toxicity. In case of prolonged use, monitoring durin Přečtěte si celý dokument